Credit Suisse Healthcare Conference November , 2014, Phoenix, AZ Bill Rutherford – CFO and Executive Vice President Vic Campbell – Senior Vice President Dr. Ravi Chari – Vice President – Clinical Excellence Mark Kimbrough – Vice President – Investor Relations

1 1 1 FORWARD-LOOKING STATEMENTS AND NON-GAAP FINANCIAL MEASURES This presentation may contain certain forward-looking statements provided by Company management. These statements are intended to be covered by the safe-harbor provisions of the Private Securities Litigation Reform Act of Forward- looking statements include all statements that do not relate solely to historical or current facts, including statements regarding future operations, financial results, cash flows, costs and cost management initiatives, capital structure management, growth rates, and operational and strategic initiatives, and can also be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “intend,” “plan,” “initiative,” “continue” or words or phrases of similar meaning. These forward-looking statements speak only as of the date hereof and are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control. These risks and uncertainties are described in headings such as “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2013 and other reports filed with the Securities and Exchange Commission. As a consequence, current plans, anticipated actions and future financial position and results of operations may differ significantly from those expressed in any forward-looking statements in today’s presentation. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented and we do not intend to update any of these forward-looking statements. The presentation may contain certain non-GAAP measures, including Adjusted EBITDA. The Company’s earnings releases for the year ended December 31, 2013, and for the quarter and nine months ended September 30, 2014, located on the Company’s investor relations page at include reconciliations of the difference between certain non-GAAP financial measures with the most directly comparable financial measure calculated in accordance with GAAP. These non-GAAP financial measures should not be considered alternatives to the GAAP financial measures. References to “Company” used herein refer to HCA Holdings, Inc. and its affiliates, unless otherwise stated or indicated by context.

22 Most people know HCA as a hospital company, with leading market positions across the U.S. Salt Lake City Denver Kansas City Miami/Fort Lauderdale/WPB Dallas / Fort Worth San Antonio New Hampshire Western Idaho San Jose Southern California Las Vegas Idaho Falls Myrtle Beach Trident / Charleston Jacksonville North Central Florida Orlando Treasure Coast N-VA Richmond S-VA Augusta Tallahassee Wichita Oklahoma City Central Louisiana Lafayette New Orleans Panhandle El Paso Corpus Christi McAllen Brownsville Terre Haute Frankfort Chattanooga NWGA Atlanta Middle GA Anchorage Nashville Houston Tampa Austin Central London Note: Gold labels indicate top 10 domestic markets by 2013 Adjusted EBITDA.

33 HCA is the largest non-governmental hospital provider in the U.S. … and much more #1 or #2 in key markets with market shares ranging from ~ 20% to 40% Operating in 17 of 25 fastest growing MSAs with populations > 500,000 Provide ~ 4% - 5% of all U.S. hospital services Leading hospital provider (1) … Leader across a range of services … One of the largest clinical networks, with over 35K active physicians Leader in oncology clinical trials, 2 nd to MD Anderson Third largest acute inpatient psychiatric provider A leading national player in ASCs AND (1) Based on most recently available data for each metric.

4 4 4 Percentage Change From Prior Year Nine Months Ended Sept. 30, % Equivalent Admissions (1) 4.3% Revenue per Equivalent Admission (1) 7.6% Revenues 12.6% Adjusted EBITDA 32.8% Net Income Attributable to HCA Holdings, Inc. (2) 36.3% Diluted Earnings Per Share (2) (1)Same facility through 09/30/14 compared to prior year period (2)Net income attributable to HCA Holdings, Inc. and diluted earning per share exclude losses (gains) on sales of facilities, losses on retirement of debt and legal claim costs.

55 Acquisitions Cash Flow from Operations Capital Expenditures Special Dividends Share Repurchases $13.7 B $6.6 B $2.5 B $3.2B $2.75B Cash Flow Trends since March 2011 IPO* * HCA Holdings, Inc. cash flow data for the period from April 2011 through 3Q 2014

66 When thinking about growth strategies, we focus on a number of dimensions … in addition to clinical quality Breadth and depth of services Access pointsCapital deployment Core services Service Line Focus High intensity and deep service capability E.g., TAVR, Trauma, Stroke network E.g., Cardio, Neuro, ED Womens, Behavioral, Rehab 10 hospitals 3 free-standing EDs 43 medical group locations 11 urgent care centers

77 HCA States Economic Indicators – Favorable Trending % Change in Key Economic Indicators Weak Favorable -2.5%9.7% Real GDP 2013 YoY Growth 2.57% 1.84% 2.12% Median of HCA’s Top 6 States US Average Range of HCA’s Top 6 States US Range 75 th Percentile of HCA States 1.5%7.6% Personal Income 2013 YoY Growth 3.07% 2.57% 2.83% -34.2% 47.8% Single Family Housing Permits Start April 2014 YTD over PY 6.13% -0.70% 6.50% -6.0%13.0% State General Sales & Gross Receipt Taxes 2013 YoY Growth 6.56% 3.88% 5.80% -0.79% -4.3%2.1% Birth Rate 2013 YoY Growth 0.00% -0.78% 0.5%-2.5% Unemployment May 2014 over PY -1.50% -1.20% -1.35% HCA Top States: California Colorado Florida Kansas Tennessee Texas

88 Clinical Excellence is about Reducing Negative Clinical Variation  CE is our approach to clinical performance improvement that asks a physician led team to use clinical evidence to change physician practice choices and behavior to reduce negative clinical variation  HCA has created clinical data systems to measure and monitor clinical performance and a knowledge center to establish and share best evidenced care and practices  HCA achieves CE by having the team leading the care initiative take ownership and be accountable for performance improvement  We believe our CE initiatives differentiate our hospitals in the market as a premier clinical organization through: Collaborating with physicians to align practice choices with best practice Teaching facility leaders to leverage HCA’s disciplined operational management culture to achieve the same rigor around clinical performance improvement Improving patient outcomes, patient safety and patient care 1 Includes YOY impact for CE initiatives selected 7 care lines: AMI, CABG, Sepsis, Hip/Knee, Spine and Stroke 2013 Full Year CY 2014 Through June 30 th Lives Saved Mortality Rate Reduction 4.6%9.2% Complications Avoided 1, Complication Rate Reduction 8%11% Length of Stay days avoided 33,53121,995 Reduction in average LOS Source: MedPAR and Company data

99 We are confident that our core strengths will continue to position us for future success Strong operating culture Deep and experienced leadership Financial strength Scale Strong, diversified assets and markets

Credit Suisse Healthcare Conference November , 2014, Phoenix, AZ Bill Rutherford – CFO and Executive Vice President Vic Campbell – Senior Vice President Dr. Ravi Chari – Vice President – Clinical Excellence Mark Kimbrough – Vice President – Investor Relations